ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Review of Clinical Pharmacokinetic and Pharmacodynamic Relationships and Clinical Implications for Drugs Used to Treat Multi-drug Resistant Tuberculosis

Wilby, Kyle John*; Hussain, Farhat Naz
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS2020-6DOI: 10.1007/s13318-019-00604-5
5被引12阅读
引用收藏
分享

摘要

Multidrug-resistant tuberculosis (MDR-TB) is becoming a global health crisis. The World Health Organization has released new guidelines for the use of tuberculosis-active drugs for the treatment of patients with MDR-TB. Despite documented activity against tuberculosis isolates, doses and exposure targets are yet to be optimized. Our objective was therefore to review the clinical pharmacokinetic and pharmacodynamic literature pertaining to drugs recommended to treat MDR-TB and to identify target areas for future research. To date, published research is limited but studies were identified that evaluated the pharmacokinetics and pharmacodynamics of these drugs. Exposure targets were assessed and summarized for each drug. Exposure-based targets (e.g., area under the concentration curve/minimum inhibitory concentration) appear to be most commonly associated with predicting drug efficacy. Dose variation studies based on these targets were largely inconclusive. Future research should focus on determining the risks and benefits of dose optimization to meet exposure targets and improve patient outcomes. The role of therapeutic drug monitoring also remains yet to be confirmed, both from a clinical perspective as well as a resource allocation perspective in regions where MDR-TB is active.

学科与关键词

关键词
POPULATION PHARMACOKINETICSMYCOBACTERIUM-TUBERCULOSISARTIFICIAL-INTELLIGENCEAMINOSALICYLIC ACIDBEDAQUILINE TMC207MOXIFLOXACINLEVOFLOXACINMODELPHARMACOKINETICS/PHARMACODYNAMICSCYCLOSERINE
相关
加载中…
  • Quantitative assessment of the activity of antituberculosis drugs and regimens
    Chirehwa, Maxwell T.*; Velasquez, Gustavo E.; Gumbo, Tawanda; McIlleron, HelenExpert Review of Anti-Infective Therapy, 2019, 17(6): 449-457.被引 3
  • Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
    van den Elsen, Simone H. J.; Sturkenboom, Marieke G. G.; Akkerman, Onno; Barkane, Linda; Bruchfeld, Judith; Eather, Geoffrey; Heysell, Scott K.; Hurevich, Henadz; Kuksa, Liga; Kunst, Heinke; Kuhlin, Johanna; Manika, Katerina; Moschos, Charalampos; Mpagama, Stellah G.; Munoz Torrico, Marcela; Skrahina, Alena; Sotgiu, Giovanni; Tadolini, Marina; Tiberi, Simon; Volpato, Francesca; van der Werf, Tjip S.; Wilson, Malcolm R.; Zuniga, Joaquin; Touw, Daan J.; Migliori, Giovanni B.BMJ Open, 2020, 10(6): e035350.被引 5
  • Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis
    Deshpande, Devyani; Pasipanodya, Jotam G.; Mpagama, Stellah G.; Srivastava, Shashikant; Bendet, Paula; Koeuth, Thearith; Lee, Pooi S.; Heysell, Scott K.; Gumbo, Tawanda*Clinical Infectious Diseases, 2018, 67: S317-S326.被引 30
查看全部 →

发表信息

论文状态
公开发表
期刊
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
发表日期
2020-06
卷期
第 45 卷, 第 3 期
页码
305-313
DOI
10.1007/s13318-019-00604-5
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE

作者

  • W

    Wilby, Kyle John (通讯) (第一作者)

  • H

    Hussain, Farhat Naz

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417